Reverend Jesse Jackson passed away last month, leaving behind a legacy as one of America’s most prominent civil rights, religious, and political figures. One of his significant contributions was his advocacy for raising awareness about the HIV/AIDS epidemic during a time when the topic was considered taboo in political circles. In the early 1980s, when the disease first emerged, Jackson played a crucial role in pushing for more funding for research on prevention and treatment.
In 1981, health officials became aware of a mysterious disease affecting young and previously healthy gay men in the U.S. Initially reported in hospitals in New York, Los Angeles, and San Francisco, the Centers for Disease Control and Prevention coined the term AIDS (acquired immune deficiency syndrome) in 1982. The pathogen responsible for AIDS was later identified as HIV (human immunodeficiency virus).
Jackson was among the first black clergy to publicly get tested for HIV, helping to reduce the stigma associated with the disease, particularly within the African American community. He urged his fellow clergy and others to actively engage in addressing HIV and AIDS both domestically and internationally.
Through his Rainbow Coalition, which brought together marginalized groups, Jackson advocated for increased awareness, sensitivity, and research surrounding HIV/AIDS. He connected his message on HIV/AIDS to a broader call for recognizing the LGBTQ+ community as part of a coalition of disenfranchised individuals. In speeches delivered at the 1984 and 1988 Democratic National Conventions, Jackson emphasized the need for equal protection under the law for all American citizens, including those affected by AIDS.
While Jackson worked tirelessly to bring attention to the HIV/AIDS crisis, it took U.S. leaders like President Ronald Reagan several years to publicly acknowledge the disease. Reagan did not address AIDS until 1985, and it wasn’t until 1987 that he delivered a national speech on the crisis. Critics have long scrutinized Reagan’s handling of the HIV/AIDS epidemic during his presidency from 1981 to 1989.
During Reagan’s tenure, the FDA approved zidovudine in 1987 as the first antiretroviral drug for HIV treatment. Subsequent advancements in highly active antiretroviral therapies (HAART) in the mid-1990s significantly improved the life expectancy of individuals with HIV. Today, preexposure prophylaxis (PrEP) offers additional protection against contracting the virus.
Jackson’s pioneering advocacy efforts played a crucial role in shifting attitudes and behaviors surrounding HIV/AIDS. By shedding light on the challenges faced by patients and the importance of compassion and recognition, he helped pave the way for improved prevention and treatment strategies.
